ALKBH7 and NLRP3 Co-Expression: A Potential Prognostic and Immunometabolic Marker Set in Breast Cancer Subtypes
International Journal of Molecular Sciences · 02.12.2025 · 26 (23) · 11661
DOI: 10.3390/ijms262311661 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 02.12.2025. Verfasst von Adem Senturk und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, Sakarya University, Sakarya Training and Research Hospital, 54100 Sakarya, Turkey. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Biomarkers, Tumor, Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Breast cancer (BC) is a heterogeneous disease with distinct molecular subtypes that exhibit variable immune responses and metabolic profiles. Recent studies have suggested that immunometabolic pathways play a role in tumor progression and treatment resistance. This study investigates the expression patterns of ALKBH7 and NLRP3 across BC molecular subtypes and explores their relationships with clinicopathological parameters and potential immunometabolic profiles. A total of 118 BC patients were classified into HER2+, TNBC, Luminal A, and Luminal B subtypes. Gene expression levels of ALKBH7 and NLRP3 were analyzed using quantitative real-time PCR (qRT-PCR), and correlations with clinical markers were assessed. ALKBH7 and NLRP3 expression levels varied significantly between subtypes, with the highest expression observed in HER2+ tumors. Strong positive correlations were found between ALKBH7 and NLRP3 in all subtypes, particularly in HER2+ (r = 0.812, p < 0.001). Additionally, NLRP3 correlated with Ki-67 in Luminal B tumors, indicating a link between inflammation and proliferative capacity. These findings suggest that ALKBH7 may function as a dual-role biomarker involved in metabolic adaptation and immune signaling in BC. The strong co-expression of ALKBH7 and NLRP3 suggests a functional association between these molecules that may be critical in shaping the tumor microenvironment. This co-expression set, particularly in aggressive subtypes (HER2+ and TNBC), warrants further mechanistic validation as a potential prognostic marker and a novel therapeutic vulnerability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgical Oncology, Sakarya University, Sakarya Training and Research Hospital, 54100 Sakarya, Turkey.
- Department Field Crops Division, Graduate Education Institute, Sakarya University of Applied Sciences, 54100 Sakarya, Turkey.
- Department of Pharmacy Services, Pamukova Vocational School, Sakarya University of Applied Sciences, 54100 Sakarya, Turkey.
- Department of Medical Pathology, Faculty of Medicine, Sakarya University, 54100 Sakarya, Turkey.
- Department of Internal Medical Sciences, Faculty of Medicine, Sakarya University, 54100 Sakarya, Turkey.
- Department of General Surgery, Faculty of Medicine, Sakarya University, 54100 Sakarya, Turkey.
ORCID-Profile: Adem Senturk, Nur Kazan, Selen Sen, Onur Taydas, Hafize Uzun
Zitieren
APA
Senturk, A., Kazan, N., Sen, S., Cakar, G. C., Ayhan, L. T., Mutlu, F., Taydas, O., Mantoglu, B., Gunduz, Y., Ercan, M., Bayhan, Z., Yildirim, E., & Uzun, H. (2025). ALKBH7 and NLRP3 Co-Expression: A Potential Prognostic and Immunometabolic Marker Set in Breast Cancer Subtypes. International Journal of Molecular Sciences, 26(23), 11661. https://doi.org/10.3390/ijms262311661
Vancouver
Senturk A, Kazan N, Sen S, Cakar GC, Ayhan LT, Mutlu F, et al. ALKBH7 and NLRP3 Co-Expression: A Potential Prognostic and Immunometabolic Marker Set in Breast Cancer Subtypes. International Journal of Molecular Sciences. 2025;26(23):11661. doi:10.3390/ijms262311661
BibTeX
@article{Senturk2025,
author = {Senturk, Adem and Kazan, Nur and Sen, Selen and Cakar, Gozde Cakirsoy and Ayhan, Lacin Tatli and Mutlu, Fuldem and Taydas, Onur and Mantoglu, Barıs and Gunduz, Yasemin and Ercan, Metin and Bayhan, Zulfu and Yildirim, Emine and Uzun, Hafize},
title = {ALKBH7 and NLRP3 Co-Expression: A Potential Prognostic and Immunometabolic Marker Set in Breast Cancer Subtypes},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {23},
pages = {11661},
doi = {10.3390/ijms262311661}
}
EUVIMED